Regular aspirin use could slow advanced prostate cancer’s progression
The team who analyzed data from 22,071 men however found that aspirin intake before prostate cancer diagnosis was not beneficial.
New York, Jan 6 (Big Wire) Regular use of aspirin may slow down progression of advanced prostate cancer- a chronic illness that affects the men, says a new study.
Those who consumed at least three aspirin tablets a week had reduced their risk of developing or dying from advanced prostate cancer, the Wall Street Journal reported.
The researchers led by Christopher Brian Allard, MD, a urologic oncology fellow at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston assessed the relation between regular aspirin intake and lethal prostate cancer.
The team who analyzed data from 22,071 men however found that aspirin intake before prostate cancer diagnosis was not beneficial.
But the risk developing lethal prostate cancer was 24 per cent lower in men who took aspirin on a regular basis, Dr. Christopher Brian Allard explained.
Dr Allard was speaking at a press briefing held in advance of the Genitourinary Cancers Symposium 2016 in San Francisco.
The full report will be presented on January 7. Aspirin is a drug generally used as an analgesic for the treatment of fever, pain, and inflammation.
Big Wire
Recommended for you
Leave a Reply
Leave a Reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
